# Colony Bankcorp Inc: overview

CBAN · NYSE · CIK 711669 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cban.md) · [Financials](/companies/cban/financials.md) · [Filings](/companies/cban/filings.md) · [Insiders](/companies/cban/insiders.md)

Revenue is not reported in this company’s XBRL financial statements.

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Diluted EPS | $ per share | [0.32](/filings/0000711669-25-000158.md) | not reported | [0.38](/filings/0001104659-26-057671.md) | [0.46](/filings/0001104659-26-091111.md) | [0.33](/filings/0000711669-25-000158.md) | not reported | [0.39](/filings/0001104659-26-057671.md) | [0.51](/filings/0001104659-26-091111.md) |
| Free cash flow | $m | [20.2 d](/filings/0000711669-25-000158.md) | [(3.8) d](/filings/0000711669-26-000007.md) | [17.6](/filings/0001104659-26-057671.md) | [15.8 d](/filings/0001104659-26-091111.md) | [14.1 d](/filings/0000711669-25-000158.md) | [(54.3) d](/filings/0000711669-26-000007.md) | [53.8](/filings/0001104659-26-057671.md) | [8.2 d](/filings/0001104659-26-091111.md) |

- Revenue. XBRL not reported.
- Gross margin (gross profit / revenue). XBRL not reported.
- Operating margin (operating income / revenue). XBRL not reported.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | not reported | not reported | not reported | not reported |
| Diluted EPS | $ per share | [1.66](/filings/0000711669-23-000041.md) | [1.14](/filings/0000711669-24-000046.md) | [1.24](/filings/0000711669-25-000046.md) | [1.36](/filings/0000711669-26-000007.md) | [0.38](/filings/0001104659-26-057671.md) |
| Free cash flow | $m | [30.3](/filings/0000711669-23-000041.md) | [46.8](/filings/0000711669-24-000046.md) | [17.4](/filings/0000711669-25-000046.md) | [22.3](/filings/0000711669-26-000007.md) | [(6.9)](/filings/0000711669-26-000007.md) |

- Revenue. XBRL not reported.
- Gross margin (gross profit / revenue). XBRL not reported.
- Operating margin (operating income / revenue). XBRL not reported.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/cban/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $46.9m | 2,336,239 |  | Added +370,906 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $18.2m | 906,348 |  | Reduced −52,251 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $17.7m | 882,163 |  | Added +144,408 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $10.7m | 533,628 |  | Added +56,966 |
| [AMERICAN CENTURY COMPANIES INC](/funds/748054.md) | 2026-06-30 | $9.5m | 472,095 |  | Added +30,484 |
| [Petiole USA ltd](/funds/1600202.md) | 2026-06-30 | $9.0m | 448,563 |  | Reduced −6,200 |
| [BANC FUNDS CO LLC](/funds/1029311.md) | 2026-06-30 | $8.9m | 441,478 |  | Added +22,000 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $8.8m | 439,763 |  | Added +82,485 |
| [TWO SIGMA INVESTMENTS, LP](/funds/1179392.md) | 2026-06-30 | $7.4m | 370,597 |  | Added +129,844 |
| [Pacific Ridge Capital Partners, LLC](/funds/1591546.md) | 2026-06-30 | $6.4m | 319,367 |  | Reduced −2,481 |

## Recent filings

[All 960 filings](/companies/cban/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-15 | 16:15 ET | [8-K](/filings/0001104659-26-116248.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-26-116248 |
| 2026-09-17 | 08:30 ET | [8-K](/filings/0001104659-26-108432.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-108432 |
| 2026-08-05 | 16:16 ET | [10-Q](/filings/0001104659-26-091111.md) | Quarterly report, period 2026-06-30 | 0001104659-26-091111 |
| 2026-07-22 | 16:15 ET | [8-K](/filings/0001104659-26-085809.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-085809 |
| 2026-06-24 | 17:00 ET | [8-K](/filings/0001104659-26-077342.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-077342 |
| 2026-05-22 | 16:15 ET | [8-K](/filings/0001104659-26-065723.md) | 5.07 Shareholder vote results | 0001104659-26-065723 |
| 2026-05-08 | 11:00 ET | [10-Q](/filings/0001104659-26-057671.md) | Quarterly report, period 2026-03-31 | 0001104659-26-057671 |
| 2026-04-22 | 16:15 ET | [8-K](/filings/0001104659-26-046828.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-046828 |
| 2026-04-16 | 16:15 ET | [DEF 14A](/filings/0001104659-26-044388.md) | Proxy statement, period 2026-05-21 | 0001104659-26-044388 |
| 2026-03-13 | 10:02 ET | [10-K](/filings/0000711669-26-000007.md) | Annual report, period 2025-12-31 | 0000711669-26-000007 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0000711669-26-000007.md), filed Mar 13, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 711669
- Tickers: CBAN
- Exchange: NYSE
- SIC code: 6022 State Commercial Banks
- State of incorporation: GA
- Filer category: Accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 27, 2026, 16:12 ET. No prices; not investment advice.